Study Title: A Randomized Phase II Study of Venetoclax and HMA-based Therapies for theTreatment of Older and Unfit Adults With Newly Diagnosed for FLT-3 Mutated Acute Myeloid Leukemia (AML): a MyeloMATCH Treatment Trial
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Baratam, Praneeth, at baratamp@musc.edu.Study Coordinator, Baker, Hana, at bakerhan@musc.edu.Trial opened at the following institutions: Medical University of South Carolina